Copy number analysis of complement C4A, C4B and C4A silencing mutation by real-time quantitative polymerase chain reaction

Autor: Katja T. Eronen, Riitta Paakkanen, Hanna Vauhkonen, Marja-Liisa Lokki, Mikko Seppänen, Asko Järvinen
Přispěvatelé: Haartman Institute (-2014), Transplantation Laboratory, Kardiologian yksikkö, Department of Medicine, Infektiosairauksien yksikkö, Clinicum
Jazyk: angličtina
Rok vydání: 2012
Předmět:
Low protein
Complement System
Gene Dosage
COMPONENTS C4A
Polymerase Chain Reaction
DISEASE
0302 clinical medicine
Gene Frequency
Gene Duplication
Genetics of the Immune System
Copy-number variation
SYSTEMIC-LUPUS-ERYTHEMATOSUS
RCCX MODULES
Genetics
0303 health sciences
Multidisciplinary
Complement C4a
Null allele
Innate Immunity
Clinical Laboratory Sciences
3. Good health
DEFICIENCY
Real-time polymerase chain reaction
Infectious Diseases
Phenotype
030220 oncology & carcinogenesis
POPULATIONS
Medicine
Research Article
DNA Copy Number Variations
Science
Immunology
education
Copy number analysis
Biology
Real-Time Polymerase Chain Reaction
Gene dosage
Sensitivity and Specificity
Autoimmune Diseases
Immunophenotyping
Molecular Genetics
03 medical and health sciences
Immune Deficiency
Genetic Mutation
Diagnostic Medicine
Complement C4b
Humans
Genetic Testing
Gene Silencing
Allele frequency
NULL ALLELES
Genetic Association Studies
Alleles
030304 developmental biology
DNA Primers
Clinical Genetics
Models
Genetic

C4A
Personalized Medicine
Immunity
Reproducibility of Results
Human Genetics
Molecular biology
GENE
POLYMORPHISM
Gene Expression Regulation
Immune System
3121 General medicine
internal medicine and other clinical medicine

Genetics of Disease
Mutation
RISK-FACTORS
Clinical Immunology
3111 Biomedicine
Zdroj: PLoS ONE, Vol 7, Iss 6, p e38813 (2012)
PLoS ONE
ISSN: 1932-6203
Popis: Low protein levels and copy number variation (CNV) of the fourth component of human complement (C4A and C4B) have been associated with various diseases. High-throughput methods for analysing C4 CNV are available, but they commonly do not detect the most common C4A mutation, a silencing CT insertion (CTins) leading to low protein levels. We developed a SYBR® Green labelled real-time quantitative polymerase chain reaction (qPCR) with a novel concentration range approach to address C4 CNV and deficiencies due to CTins. This method was validated in three sample sets and applied to over 1600 patient samples. CTins caused C4A deficiency in more than 70% (76/105) of the carriers. Twenty per cent (76/381) of patients with a C4A deficiency would have been erroneously recorded as having none, if the CTins had not been assessed. C4A deficiency was more common in patients than a healthy reference population, (OR = 1.60, 95%CI = 1.02–2.52, p = 0.039). The number of functional C4 genes can be straightforwardly analyzed by real-time qPCR, also with SYBR® Green labelling. Determination of CTins increases the frequency of C4A deficiency and thus helps to elucidate the genotypic versus phenotypic disease associations.
Databáze: OpenAIRE